DK0798971T3 - Forøgelse af creatin- og glycogenkoncentration i muskler - Google Patents

Forøgelse af creatin- og glycogenkoncentration i muskler

Info

Publication number
DK0798971T3
DK0798971T3 DK95940388T DK95940388T DK0798971T3 DK 0798971 T3 DK0798971 T3 DK 0798971T3 DK 95940388 T DK95940388 T DK 95940388T DK 95940388 T DK95940388 T DK 95940388T DK 0798971 T3 DK0798971 T3 DK 0798971T3
Authority
DK
Denmark
Prior art keywords
creatine
amount
increase
carbohydrate
retention
Prior art date
Application number
DK95940388T
Other languages
Danish (da)
English (en)
Inventor
Paul Leonard Greenhaff
Allison Lesley Green
Ian Andrew Macdonald
Eric Hultman
Original Assignee
Univ Nottingham
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26306194&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0798971(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9425514.8A external-priority patent/GB9425514D0/en
Application filed by Univ Nottingham filed Critical Univ Nottingham
Application granted granted Critical
Publication of DK0798971T3 publication Critical patent/DK0798971T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DK95940388T 1994-12-17 1995-12-15 Forøgelse af creatin- og glycogenkoncentration i muskler DK0798971T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9425514.8A GB9425514D0 (en) 1994-12-17 1994-12-17 Retention of creatine in the body
GBGB9517443.9A GB9517443D0 (en) 1994-12-17 1995-08-25 Increasing creatine and glycogen concentration in muscle
PCT/GB1995/002933 WO1996018313A1 (fr) 1994-12-17 1995-12-15 Accroissement des concentrations de creatine et de glycogene dans les muscles

Publications (1)

Publication Number Publication Date
DK0798971T3 true DK0798971T3 (da) 2000-11-13

Family

ID=26306194

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95940388T DK0798971T3 (da) 1994-12-17 1995-12-15 Forøgelse af creatin- og glycogenkoncentration i muskler

Country Status (11)

Country Link
US (1) US5968900A (fr)
EP (1) EP0798971B1 (fr)
AT (1) ATE194462T1 (fr)
AU (1) AU4185696A (fr)
CA (1) CA2208047C (fr)
DE (1) DE69518008T2 (fr)
DK (1) DK0798971T3 (fr)
ES (1) ES2150020T3 (fr)
GB (1) GB9517443D0 (fr)
PT (1) PT798971E (fr)
WO (1) WO1996018313A1 (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7150880B2 (en) * 1996-05-31 2006-12-19 The Original Creatine Patent Co. Ltd. Compositions containing creatine and creatinine and a methyl xanthine
US6080788A (en) * 1997-03-27 2000-06-27 Sole; Michael J. Composition for improvement of cellular nutrition and mitochondrial energetics
US6159942A (en) * 1998-06-19 2000-12-12 Bioenergy, Inc. Compositions for increasing energy in vivo
US6218366B1 (en) 1998-06-19 2001-04-17 Bioenergy, Inc. Method for raising the hypoxic threshold
US20020119933A1 (en) 2000-07-28 2002-08-29 Butler Terri L. Compositions and methods for improving cardiovascular function
US6429198B1 (en) 1999-04-12 2002-08-06 Bioenergy Inc. Compositions for increasing athletic performance in mammals
US6534480B2 (en) 1999-06-17 2003-03-18 Bioenergy Inc. Compositions for increasing energy in vivo
FR2797767B1 (fr) 1999-08-27 2002-06-14 Centre Nat Rech Scient Utilisation d'acides amines pour la fabrication de medicaments destines au traitement des insulino-resistances
GB9924650D0 (en) 1999-10-19 1999-12-22 Marathade Ltd Energy bar
US6703370B1 (en) 1999-10-27 2004-03-09 Bioenergy, Inc. Use of ribose to treat fibromyalgia
AU1800801A (en) * 1999-11-17 2001-05-30 Eric H. Kuhrts Exercise and muscle enhancement formulations
US6399661B1 (en) 2000-06-26 2002-06-04 Jeffrey M. Golini Oral creatine supplement and method for making same
US20030212134A1 (en) * 2001-04-16 2003-11-13 Dykstra John C. Combination of pinitol and creatine to enhance uptake and retention of creatine
US20030013767A1 (en) * 2001-07-13 2003-01-16 Samuel Bessman Method of treating weight loss using creatine
US20040052852A1 (en) * 2001-09-25 2004-03-18 Michael Farber Carbohydrate-based delivery system for creatine and other bioactive ingredients
US7067150B2 (en) 2002-04-16 2006-06-27 Scepter Holdings, Inc. Delivery systems for functional ingredients
WO2003088947A1 (fr) * 2002-04-22 2003-10-30 Experimental & Applied Sciences, Inc. Complements alimentaires contenant une combinaison de 4-hydroxyisoleucine et de creatine
WO2004069236A1 (fr) 2003-02-06 2004-08-19 Otsuka Pharmaceutical Factory, Inc. Inhibiteur de l'augmentation du taux de glycemie peri-operatoire
US7504118B2 (en) * 2003-04-11 2009-03-17 Fhg Corporation Dietary supplements containing extracts of cinnamon and methods of using same to enhance creatine transport
AU2005244162B2 (en) * 2004-05-07 2010-12-09 Thermo Formulations Ltd. Nutritional composition for increasing creatine uptake in skeletal muscle
MX2007002209A (es) * 2004-08-25 2007-11-08 Multi Formulations Ltd Composiciones y metodos para activar la sintesis de proteinas y para desactivar procesos de catabolicos dentro del musculo esqueletico.
WO2007095716A1 (fr) * 2006-02-23 2007-08-30 Iomedix Sleep International Srl Compositions et méthodes pour l'induction et la conservation d'un sommeil de qualité
US8613959B2 (en) * 2009-02-10 2013-12-24 Fhg Corporation Dietary supplements containing extracts of Nelumbo and processes of using same
US8703719B1 (en) 2009-05-18 2014-04-22 Bio-Engineered Supplements And Nutrition, Inc. Method and composition for improved muscle performance
CN108473384A (zh) 2015-10-27 2018-08-31 细胞酶动物营养品公司 动物营养成分及相关方法
US10674746B2 (en) 2015-10-27 2020-06-09 Cytozyme Animal Nutrition, Inc. Animal nutrition compositions and related methods
EP3411041A1 (fr) 2016-02-01 2018-12-12 RiboCor, Inc. Utilisation de ribose pour le traitement de sujets présentant une insuffisance cardiaque congestive

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1240336B (it) * 1990-03-21 1993-12-07 Setra Composizioni farmaceutiche,dietetiche o veterinarie ad attivita' eumetabolica
GB9215746D0 (en) * 1992-07-24 1992-09-09 Hultman Eric A method of increasing creatine supply depot

Also Published As

Publication number Publication date
AU4185696A (en) 1996-07-03
MX9704388A (es) 1998-07-31
EP0798971B1 (fr) 2000-07-12
US5968900A (en) 1999-10-19
EP0798971A1 (fr) 1997-10-08
CA2208047C (fr) 2003-07-15
DE69518008D1 (de) 2000-08-17
DE69518008T2 (de) 2001-05-17
PT798971E (pt) 2000-12-29
WO1996018313A1 (fr) 1996-06-20
GB9517443D0 (en) 1995-10-25
ATE194462T1 (de) 2000-07-15
CA2208047A1 (fr) 1996-06-20
ES2150020T3 (es) 2000-11-16

Similar Documents

Publication Publication Date Title
ATE194462T1 (de) Steigerung der kreatin und glykogen konzentration im muskel
DE2556100C2 (fr)
US5843919A (en) Composition and method for the treatment of arthritis
US20030069171A1 (en) Nutritional composition for the treatment of connective tissue
BR0109336A (pt) Medicamento para a prevenção, melhora e/ou tratamento de uma complicação diabética, droga medicinal adequada ou utilizável como o mesmo, método para prevenir, melhorar e/ou tratar a complicação diabética, e a neuropatia, e, usos de um agente redutor do açúcar no sangue pós-prandial e pelo menos um agente selecionado de um agente anti-hipertensivo, um agente vasodilatador e um agente anti-hiperlipidêmico
US6660308B1 (en) Beverage and additive for the ill
CY1117668T1 (el) Φαρμακευτικες συστασεις περιλαμβανουσες ινσουλινη συμπλοκοποιημενη με μια δικετοπιπεραζινη
NO20023684D0 (no) Pediatrisk formulering
CA2129541A1 (fr) Methode pour favoriser la retention d'azote chez les humains
JPS6425A (en) Medicinal composition for treating hiv infection containing dsrna and reverse transcriptase inhibitor
KR920702217A (ko) 말라리아 치료 조성물
KR940018089A (ko) 내부조직의 방사선 손상에 대한 예방 및 처치방법
KR880005933A (ko) 비타민 b6-함유 약제학적 제제
KR920702225A (ko) 약학 조성물
KR900007434A (ko) 시스타틴을 유효 성분으로하는 치료제
JPS57126420A (en) Drug for digestive organ
US6979458B1 (en) Beverage and additive for wellness
EP0459377B1 (fr) Utilisation de la prostaglandine E1 pour guérir l'impuissance érectile masculine
KR930003913A (ko) 덱스트로메토르판의 진해효과를 증진시키기 위한 방법 및 약제학적 조성물
Drill Effect of Vitamin B1 and Vitamin B2 Complex on the Loss of Weight Produced in Rats by Experimental Hyperthyroidism
EP0076841A4 (fr) Solution amelioree pour nutrition par voie parenterale.
JPH03501027A (ja) エネルギー基質
DK1494746T3 (da) Insulin til anvendelse i en dosering
KR890015746A (ko) 메게스트롤 아세테이트로 aids 악액질을 치료하는 방법
Sudatri et al. Side effect of long term injection of high dose whitening vitamin C to plasma glucose and cholesterol level